Authored by: Jo Ann Saitta
Pharmaceutical companies face immense pressure and risk when bringing new drugs and therapies to market. Every launch demands coordination, informed decision-making, and a readiness to solve problems as they emerge – all against a backdrop of extreme competition and finite resources.
That’s why, for some time now, companies have been assessing and integrating AI solutions best suited to meet these challenges. As we’ve explored in past pieces like AI as the Input, Not the Answer and Why AI Needs Humans, AI delivers the most value when paired with human judgment. Agentic AI is yet another leap forward, acting on the user’s behalf (in line with human-set criteria) to monitor signals, identify deviations, trigger tasks, and recommend actions. It has a tremendous capability to predict launch risk
However, to capitalize on these capabilities while avoiding AI overwhelm, there is a need to create a central launch command center, which is precisely what we’re doing at Putnam for our clients. We’re taking it a step further by combining our internal AI solutions like Navigator AI™ our strategic intelligence platform, with its built-in conversational AI and agentic AI to form powerful command centers – a place to bring together everything to make more informed decisions. Using generative AI to provide real-time insights and predictive recommendations, supporting readiness planning, competitive analysis, and trend monitoring.
In this blog, we explore the extraordinary capabilities of creating these Launch command centers and how they can be built to predict risk (supply chain issues, messaging compliance issues, or competitive activation) and recommend corrective actions.
Given the complexity and opportunities that agentic AI presents, the next natural step is to provide a central hub where a user can consolidate all moving parts for a product launch. These launch command centers become a master deck that can look at the entire journey, synthesize vast amounts of data, automate tasks, and provide real-time insights that support informed decision-making like never before.
Launch command centers can typically bring a host of opportunities by leveraging agentic AI:
A command center is a tremendously powerful tool for users, as it can monitor Key Performance Indicators (KPIs), automatically flag deviations from the forecast, trigger necessary tasks, and notify the appropriate team member, ensuring the launch stays on course.
And upon detecting underperformance (e.g., delayed access uptake), it autonomously analyzes signals, such as sales data, payer activity, and HCP sentiment, to propose remediation actions directly to the launch leader or team. It also predicts upcoming launch risks (e.g., supply chain issues, messaging compliance problems, or competitive activation) and recommends corrective scenarios. A command center speeds up issue identification and reduces the response time from days to hours, reducing manual coordination. Its ability to multitask and bring everyone together on a single script is not only exciting but also a game-changer competitively.
It all starts with a plan. Our proprietary product LaunchNav, leverages data from 800+ Inizio launch engagements and AI to develop bespoke plans for client launch teams. Our product maps activity-level tasks with defined start/end dates and benchmarks to ensure cross-functional harmony. Additionally, this tool provides benchmarking capabilities and assessments for client’s own developed launch plans. It enables clients to validate their assumptions and identify gaps from an external proprietary data source and experts.
A launch command center primarily unifies AI solutions, and internally, we use Navigator AI™ to provide a deep layer of cross-functional launch-process oversight and specialized performance metrics.
Navigator AI™ acts as a dedicated navigational layer, ensuring all stakeholders align on activity-level tasks, milestones, and launch readiness. It can complement the predictive AI of the central command center by providing granular tracking capabilities, utilizing its own proprietary benchmarks and methodologies to flag critical path deviations. This integration allows the command center to leverage a wider array of data sources and expert models, delivering comprehensive, actionable insights directly to the launch leader and their team.
Once a drug or therapy is launched, tracking tools are essential for course-correction decision-making to deal with deviations from plan and ensure success. That’s why launch trackers are tremendously helpful, as they allow continuous monitoring, providing real-time cross-functional insights necessary for effective launch management.
A launch tracker can leverage an autonomous reporting agent to generate and distribute executive summaries periodically, as well as PowerPoint reports with trend commentary, reducing the burden of manual reporting. They can also leverage a benchmark comparison agent that evaluates each country’s launch performance against prior internal, country, or global benchmarks, automatically flagging anomalies and alerting country-level launch leaders to areas needing attention.
Add to this a continuous learning agent that feeds post-launch learnings and insights back into the launch knowledge base for model fine-tuning and future planning, and you have a potent tool. Powerful launch trackers can increase visibility for leadership and sustain a continuous learning cycle where nothing is missed.
An essential part of a command center is conversational AI, which moves the organization from static reports to interactive decision-making. It can:
Conversational AI shifts information retrieval from static to interactive decision support, reducing time and enabling focus on the insights required for decision-making.
By developing a launch command center with an execution-focused launch tracker and an interactive chatbot, pharma leaders can deploy sophisticated AI that ensures launch excellence and competitive advantage with confidence and complete human oversight.
Ready to create a launch command center? Contact us here.
Jump to a slide with the slide dots.
Key insights from ISPOR Europe 2025 on evolving HEOR, RWE, AI-driven evidence, patient-centered outcomes, and the future of market access.
Read moreAs obesity care surges past $100B, biopharma, payers, and providers face a new era of opportunity.
Read moreAt ESMO 2025, science set the pace, but Precision Medical Affairs defined the path, turning complexity into clarity and innovation into impact.
Read more